Department: Biostatistics

Greg Enas received his Ph.D. in biostatistics from VCU in 1982. Upon graduation, Enas joined Eli Lilly and Company in Indianapolis as a senior statistician, ultimately serving as the corporate senior leader for global statistics, mathematical sciences and decision sciences within the company. He then assumed a leadership position within global regulatory affairs in 1998 and retired from Lilly in 2011 as the senior director of global regulatory affairs, diabetes. In this role, he oversaw the delivery of world-class regulatory strategies, negotiated for the development and approval of new products with the FDA and coordinated strategies for aligned global implementation. Enas is currently a senior advisor for FaegreBD Consulting with offices in Indianapolis, and Washington, D.C.

 

Back to Listing